This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| STANDARD CHARTERED PLC | 523.2 | 2.3% |
| BRITISH AMERICAN TOBACCO PLC | 3,033.0 | 2.0% |
| LLOYDS BANKING GROUP PLC | 55.0 | 1.9% |
| SEVERN TRENT PLC | 2,891.0 | 1.4% |
| NATIONAL GRID PLC | 1,081.0 | 1.4% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| ROYAL MAIL PLC | 496.5 | -5.6% |
| B&M EUROPEAN VALUE RETAIL SA | 564.8 | -5.3% |
| OCADO GROUP PLC | 1445.0 | -4.9% |
| RIGHTMOVE PLC | 692.8 | -4.5% |
| HALMA PLC | 2657.0 | -4.4% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,543 | -0.3% | 12.0% |
| DOW JONES INDUS. AVG | 35,912 | -0.6% | 16.5% |
| DAX INDEX | 15,883 | -0.9% | 15.2% |
| NIKKEI 225 | 28,124 | -1.3% | -1.4% |
| S&P/ASX 200 INDEX | 7,394 | -1.1% | 10.1% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 83.82 | 2.07% |
| Brent Crude (ICE) | USD/bbl. | 86.06 | 1.88% |
| Gold Spot | USD/t oz. | 1,818 | -0.3% |
| Copper (Comex) | USd/lb. | 442 | -2.8% |
Click graph to enlarge
The UK 100 is called to open +23 points today at 7565. The UK’s bluechip index looks set to nudge higher once more today. On Friday the picture was mainly positive, The Dow Jones slid 201.81 points, or 0.56%, to 35,911.81. The S&P edged up 0.08% to 4,662.85, while the tech-heavy Nasdaq outperformed with a 0.59% gain to close at 14,893.75. Markets in Asia this morning were mixed, this comes as China’s latest economic data portrayed a mixed picture that, ultimately, led to a cut to bank lending rates. Japan, meanwhile, is reported to be ready to raise its forecasts for growth and inflation before ‘telegraphing’ its stance on interest rates. The Nikkei in Japan rose 0.74% on Monday while South Korea’s Kospi fell 1.09%. China’s Shanghai Composite gained 0.63% but Hong Kong’s Hang Seng index fell 0.64%. On the oil markets, Brent crude hit a three-year high of almost $84 a barrel.
AstraZeneca breast cancer treatment Enhertu wins priority review from US FDA.
Ashmore report that their Q2 FY22 was down 4.4% to $87.3bn v $91.3bn in the prior quarter.
BP has signed a deal with the Omani government to develop a renewable energy and green hydrogen project by 2030.
GlaxoSmithKline have rejected a £50bn bid from Unilever for their consumer healthcare business.
Hikma Pharmaceutical agrees to acquire Canadian assets of Teligent for $45.8m.
Taylor Wimpey report that their FY21 UK home completions were up 47% to 14,087 (9,609 the year before) as private average selling prices increased 3% to £332,000. Their Dec 31st order book was down to £2.55bn (£2.68bn the prior year).
Unilever plans to sell lower growth brands and businesses.
Berenberg Upgrades GKP to Buy from Hold (5 Buys / 1 Hold / 0 Sells)
Bernstein Downgrades Unilever to Underperform from Market Perform (5 Buys / 7 Holds / 1 Sell)
HSBC Downgrades Hiscox to Hold from Buy (2 Buys / 11 Holds / 0 Sells)
HSBC Upgrades Admiral Group to Hold from Reduce (1 Buy / 5 holds / 4 Sells)
UBS Upgrades Antofagasta to Neutral from Sell (3 Buys / 9 Holds / 3 Sells)
Ashmore
Taylor Wimpey
Hays
Rio Tinto
Eurogroup Meeting
Chinese Gross Domestic Product
Chinese Industrial Production
Chinese NBS Press Conference
Chinese Retail Sales
UK NIESR GDP Estimate
Bank of Canada Business Outlook Survey
FTSE 100:
Compass Group
FTSE 250:
Diploma
Games Workshop Group
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.